Madeline H. Kowalski,Huijun Qian,Ziyi Hou,Jonathan D. Rosen,Amanda L. Tapia,Yue Shan,Deepti Jain,Maria Argos,Donna K. Arnett,Christy Avery,Kathleen C. Barnes,Lewis C. Becker,Stephanie A. Bien,Joshua C. Bis,John Blangero,Eric Boerwinkle,Donald W. Bowden,Steve Buyske,Jianwen Cai,Michael H. Cho,Seung Hoan Choi,Helene Choquet,L. Adrienne Cupples,Mary Cushman,Michelle Daya,Paul S. de Vries,Patrick T. Ellinor,Nauder Faraday,Myriam Fornage,Stacey Gabriel,Santhi K. Ganesh,Misa Graff,Namrata Gupta,Jiang He,Susan R. Heckbert,Bertha Hidalgo,Chani J. Hodonsky,Marguerite R. Irvin,Andrew D. Johnson,Eric Jorgenson,Robert Kaplan,Sharon L. R. Kardia,Tanika N. Kelly,Charles Kooperberg,Jessica A. Lasky-Su,Ruth J. F. Loos,Steven A. Lubitz,Rasika A. Mathias,Caitlin P. McHugh,Courtney Montgomery,Jee-Young Moon,Alanna C. Morrison,Nicholette D. Palmer,Nathan Pankratz,George J. Papanicolaou,Juan M. Peralta,Patricia A. Peyser,Stephen S. Rich,Jerome Rotter,Edwin K. Silverman,Jennifer A. Smith,Nicholas L. Smith,Kent D. Taylor,Timothy A. Thornton,Hemant K. Tiwari,Russell P. Tracy,Tao Wang,Scott T. Weiss,Lu-Chen Weng,Kerri L. Wiggins,James G. Wilson,Lisa R. Yanek,Sebastian Zollner,Kari E. North,Paul L. Auer,Laura M. Raffield,Alexander P. Reiner,Yun Li

Abstract:Most genome-wide association and fine-mapping studies to date have been conducted in individuals of European descent, and genetic studies of populations of Hispanic/Latino and African ancestry are still limited. In addition to the limited inclusion of these populations in genetic studies, these populations have more complex linkage disequilibrium structure that may reduce the number of variants associated with a phenotype. In order to better define the genetic architecture of these understudied populations, we leveraged >100,000 phased sequences available from deep-coverage whole genome sequencing through the multi-ethnic NHLBI Trans-Omics for Precision Medicine (TOPMed) program to impute genotypes into admixed African and Hispanic/Latino samples with commercial genome-wide genotyping array data. We demonstrate that using TOPMed sequencing data as the imputation reference panel improves genotype imputation quality in these populations, which subsequently enhances gene-mapping power for complex traits. For rare variants with minor allele frequency (MAF) < 0.5%, we observed a 2.3 to 6.1-fold increase in the number of well-imputed variants, with 11-34% improvement in average imputation quality, compared to the state-of-the-art 1000 Genomes Project Phase 3 and Haplotype Reference Consortium reference panels, respectively. Impressively, even for extremely rare variants with sample minor allele count <10 (including singletons) in the imputation target samples, average information content rescued was >86%. Subsequent association analyses of TOPMed reference panel-imputed genotype data with hematological traits (hemoglobin (HGB), hematocrit (HCT), and white blood cell count (WBC)) in ~20,000 self-identified African descent individuals and ~23,000 self-identified Hispanic/Latino individuals identified associations with two rare variants in the HBB gene (rs33930165 with higher WBC (p=8.1×10 −12 ) in African populations, rs11549407 with lower HGB (p=1.59×10 −12 ) and HCT (p=1.13×10 −9 ) in Hispanics/Latinos). By comparison, neither variant would have been genome-wide significant if either 1000 Genomes Project Phase 3 or Haplotype Reference Consortium reference panels had been used for imputation. Our findings highlight the utility of TOPMed imputation reference panel for identification of novel associations between rare variants and complex traits not previously detected in similar sized genome-wide studies of under-represented African and Hispanic/Latino populations. Author summary Admixed African and Hispanic/Latino populations remain understudied in genome-wide association and fine-mapping studies of complex diseases. These populations have more complex linkage disequilibrium (LD) structure that can impair mapping of variants associated with complex diseases and their risk factors. Genotype imputation represents an approach to improve genome coverage, especially for rare or ancestry-specific variation; however, these understudied populations also have smaller relevant imputation reference panels that need to be expanded to represent their more complex LD patterns. In this study, we leveraged >100,000 phased sequences generated from the multi-ethnic NHLBI TOPMed project to impute in admixed cohorts encompassing ~20,000 individuals of African ancestry (AAs) and ~23,000 Hispanics/Latinos. We demonstrated substantially higher imputation quality for low frequency and rare variants in comparison to the state-of-the-art reference panels (1000 Genomes Project and Haplotype Reference Consortium). Association analyses of ~35 million (AAs) and ~27 million (Hispanics/Latinos) variants passing stringent post-imputation filtering with quantitative hematological traits led to the discovery of associations with two rare variants in the HBB gene; one of these variants was replicated in an independent sample, and the other is known to cause anemia in the homozygous state. By comparison, the same HBB variants would not have been genome-wide significant using other state-of-the-art reference panels due to lower imputation quality. Our findings demonstrate the power of the TOPMed whole genome sequencing data for imputation and subsequent association analysis in admixed African and Hispanic/Latino populations.

Frequency of pharmacogenomic variation and medication exposures among All of Us Participants

Evaluating the frequency and the impact of pharmacogenetic alleles in an ancestrally diverse Biobank population

The frequency of pathogenic variation in the All of Us cohort reveals ancestry-driven disparities

Genomic data in the All of Us Research Program

Patterns of pharmacogenetic variation in nine biogeographic groups

A call for increased inclusivity and global representation in pharmacogenetic testing

Genetic ancestral patterns in alleles: structural variants, rare variants, and clinical associations in 479,144 UK Biobank genomes

Overcoming Barriers to Discovery and Implementation of Equitable Pharmacogenomic Testing in Oncology

Large-Scale Pharmacogenomics Analysis of Patients With Cancer Within the 100,000 Genomes Project Combining Whole-Genome Sequencing and Medical Records to Inform Clinical Practice

Genetic ancestry and population structure in the All of Us Research Program cohort

Increased Genetic Diversity of ADME Genes in African Americans Compared with Their Putative Ancestral Source Populations and Implications for Pharmacogenomics

Implementation of preemptive DNA sequence–based pharmacogenomics testing across a large academic medical center: The Mayo-Baylor RIGHT 10K Study

Proteogenomic analysis integrated with electronic health records data reveals disease-associated variants in Black Americans

Advancing pharmacogenomic research in US Hmong populations: prevalence of key single nucleotide variations in California Hmong

Pharmacogenetic analysis of structural variation in the 1000 genomes project using whole genome sequences

The variation landscape of in a multi-ethnic Asian population

Analytics of the clinical implementation of pharmacogenomics testing in 12 758 individuals

Pharmacogenomic insights in psychiatric care: uncovering novel actionability, allele-specific CYP2D6 copy number variation, and phenoconversion in 15,000 patients

Use of >100,000 NHLBI Trans-Omics for Precision Medicine (topmed) Consortium Whole Genome Sequences Improves Imputation Quality and Detection of Rare Variant Associations in Admixed African and Hispanic/Latino Populations

A retrospective analysis of preemptive pharmacogenomic testing in 22,918 individuals from China

Phenome-Wide Association of APOE Alleles in the All of Us Research Program